Pneumologia Vol. 67 Nr. 1
Journal indexed in SCOPUS and EBSCO
Member of COPE
Impact factor SJR 0.145
Copyright Romanian Society of Pneumology
Dorim să stabilim schimburi cu alte publicaţii.
University scientific research should never accept funding from companies operating in the same sector in which it is applied, due to evident conflicts of interest that could influ-ence or undermine the results of the research itself.
Progression in the medical career continues to rely to a large extent on the scientific publications in the portfolio of each physician.
Every year, researchers are doing important progresses in discovering new molecules or in the revival of some old drugs and strategies for diminishing the burden of Chronic Obstructive Pulmonary Disease (COPD).
Starting in 1999, the medical community took a real close look at medical errors, when the Institute of Medicine (IOM) released a defining report entitled To Err Is Human(1). Although this report has opened the way for research on this subject and significant advances have been made since then, medical errors continue to plague the medical system and the safety of patients.
Occult foreign body aspiration is a rare event in the adult population, being mostly seen in children. The aspiration may remain undiagnosed for a long period of time in patients who cannot recall the time when it took place, and mistaken for other pathologies such as bron-chial asthma, lung cancer, pneumonia or tuberculosis(1). Due to the small number of cases encountered, there is no standard in the management of these cases.
Sarcoidosis is an inflammatory systemic disease of unknown etiology characterized by the presence of non-caseating granulomas with the involvement of any organ(1). The primary location of the disease is the pul-monary system, in more than 90% of cases(2). Although abdominal involvement is uncommon, it can more easily mimic an infectious or a neoplastic pathology, causing real differential diagnosis issues(3).
Romania has the highest tuberculosis (TB) notifica-tion rate in the European Union (EU), five times over the average, contributing with 20% of the TB cases reported in the EU, while it has only 4% of the EU popu-lation(1).
Tuberculosis is an infectious disease that occurs in patients with impaired immunity, as for example in patients with malignancy. This association aggravates the evolution of both diseases, posing problems of diag-nosis and treatment. In this paper we present the case of a patient with two solid malignancies that develops tuberculosis concomitant with the second malignancy.
Severe pulmonary impairment in young patients is particularly important because of its impact on the qual-ity of life, its significant economic burden, as well as due to the limited therapeutic options available.
Letters to the editor:
The Patient Safety concept must be perceived as the responsibility of all healthcare professionals in their effort to do the right thing for their patients and to limit error.